94835 ⎘
Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups - ; Six-membered rings; Thiadiazines; Hydrogenated thiadiazines 1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom
NOVEL ATP-SENSITIVE POTASSIUM CHANNEL POTENTIATORS, THEIR PREPARATION AND USE
#23-AMINO-4H-BENZO[E][1,2,4]THIADIAZINE 1,1-DIOXIDE DERIVATIVES AS INHIBITORS OF MRGX2
#3MRGPRX2 MODULATORS AND RELATED METHODS OF TREATMENT
#4MYELINATION STIMULATOR COMPOUNDS, AND METHODS OF TREATMENT
#5SALTS OF POTASSIUM ATP CHANNEL OPENERS AND USES THEREOF
#6Therapeutics for the treatment of glaucoma
#7Method for preparing diazoxide
#83-amino-4H-benzo[e][1,2,4]thiadiazine 1,1-dioxide derivatives as inhibitors of MRGX2
#9Salts of potassium ATP channel openers and uses thereof
#10Fused [1,2,4]Thiadiazine Derivatives Which Act as KAT Inhibitors of the MYST Family
#11Myelination stimulator compounds, and methods of treatment
#12Therapeutics for the treatment of glaucoma
#13Salts of potassium ATP channel openers and uses thereof
#14SALTS OF POTASSIUM ATP CHANNEL OPENERS AND USES THEREOF
#15Orexin receptor antagonists
#16Salts of potassium ATP channel openers and uses thereof
#17Orexin receptor antagonists
#18Therapeutics for the treatment of glaucoma
#19C6-spiro iminothiadiazine dioxides as BACE inhibitors, compositions, and their use
#20Orexin receptor antagonists
#21Fused ring analogues of anti-fibrotic agents
#22Orexin receptor antagonists
#23Compositions and methods for the treatment of metabolic syndrome
#24Modulators for Sirt5 and assays for screening same
#25Salts of potassium ATP channel openers and uses thereof
#26Fused ring analogues of anti-fibrotic agents
#27Salts of potassium ATP channel openers and uses thereof
#28FUSED RING ANALOGUES OF ANTI-FIBROTIC AGENTS
#29Phenylalanine derivatives
#30Quinoline derivatives as PI3 kinase inhibitors
#31Phenylalanine derivatives
#32Fused ring heterocycles as potassium channel modulators
#33SALTS OF POTASSIUM ATP CHANNEL OPENERS AND USES THEREOF
#34QUINOLINE DERIVATIVES AS P13 KINASE INHIBITORS
#35Quinoline derivatives as P13 kinase inhibitors
#36NOVEL SUBSTITUTED-1, 1-DIOXO-BENZO[1,2,4]THIADIAZIN-3ONES, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
#37SALTS OF POTASSIUM ATP CHANNEL OPENERS AND USES THEREOF
#382-(2-hydroxyphenyl) benzothiadiazines useful for treating obesity and diabetes
#39Salts of potassium ATP channel openers and uses thereof
#40Quinoline derivatives as PI3 kinase inhibitors
#41Anti-infective agents
#42Fused ring heterocycles as potassium channel modulators
#43Benzothiadiazine compounds
#44Arylamine-substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists
#45Salts of potassium ATP channel openers and uses thereof
#46Anti-infective agents
#47Histone deacetylase inhibitors
#48Phenylalanine derivatives
#49Il-8 receptor antagonists
#50Benzothiadiazine compounds
#51Benzothiadiazine compounds
#52Method of producing amide compound
#53Fluorinated benzothiadiazine compounds
#54Anti-infective agents
#55Phenylalanine derivatives
#56Dye-forming coupler and silver halide color photographic light-sensitive material
#57Fused ring heterocycles as potassium channel modulators
#58Arylamine-substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists
#59Benzothiazine and benzothiadiazine compounds
#60Method of determining potential allosterically-binding matrix metalloproteinase inhibitors